Financials
- Market Capitalization 290.75 M
- Employee 75
- Founded 2007
- CEO N/A
- Website www.cartesiantherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG001J19Q25
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.44
Relación precio/flujo de caja
66.95
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3350 | FATE Fate Therapeutics, Inc. - Common Stock | 2.42 USD | -4.72% | +3.86% | +3.86% | +124.07% | 289.97 M USD | ||
| 3351 | FULC Fulcrum Therapeutics, Inc. - Common Stock | 3.86 USD | +0.26% | +0.78% | +4.61% | -42.47% | 294.51 M USD | ||
| 3362 | LCTX Lineage Cell Therapeutics, Inc. Common Stock | 1.12 USD | -4.27% | +3.70% | +5.66% | -34.77% | 283.26 M USD | ||
| 3375 | IVVD Invivyd, Inc. - Common Stock | 0.96 USD | +6.67% | -4.00% | +62.71% | -8.57% | 282.97 M USD |